Form 4: Alignment Healthcare CMO Executes Stock Sale

Sentiment:

Statement of Changes in Beneficial Ownership


Chief Medical Officer Hyong Kim sold 35,951 shares of Alignment Healthcare, Inc. common stock.

Summary

  • Hyong Kim, Chief Medical Officer of Alignment Healthcare, Inc., sold 35,951 shares of common stock.
  • The shares were sold at a weighted-average price of $19.8589 per share.
  • The transaction was executed on June 12, 2026, pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2026.
  • Following the transaction, the reporting person retains beneficial ownership of 331,750 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was executed via a pre-planned 10b5-1 program, which is a routine financial management activity for executives.

Positives

  • The sale was conducted under a pre-arranged Rule 10b5-1 trading plan, which is a standard mechanism for executives to sell shares without concerns regarding insider trading.

Negatives

  • The transaction represents a reduction in the insider's direct equity stake in the company.

Risks

  • Insider selling can sometimes be perceived by the market as a lack of confidence in future share price appreciation, though this was a planned sale.

Future Outlook

No specific forward-looking guidance regarding company operations was provided in this filing.

Industry Context

StockSavvy.ai notes that executive stock sales under Rule 10b5-1 plans are common in the healthcare sector and generally do not signal fundamental changes in company strategy or performance.

Comparison to Industry Standards

  • The use of Rule 10b5-1 plans is the industry standard for corporate officers to manage personal liquidity while maintaining regulatory compliance.

Stakeholder Impact

  • Minimal impact expected on shareholders as the sale was pre-planned and represents a small portion of the officer's total holdings.

Next Steps

  • No future actions or milestones were disclosed in this filing.

Key Dates

DateDescription
03/13/2026Date of Rule 10b5-1 plan adoption.
06/12/2026Date of the reported stock sale transaction.
06/15/2026Date of filing.

Keywords

Alignment Healthcare, ALHC, Insider Trading, Form 4, Chief Medical Officer, Stock Sale

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.